DB
TEVA icon

Danske Bank’s Teva Pharmaceuticals TEVA Stock Holding History

Danske Bank’s Portfolio TEVA Stock Details TEVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$8.58M Buy
284,939
+12,400
+5% +$399K 0.02% 461
2025
Q4 		$8.51M Buy
272,539
+24,400
+10% +$601K 0.02% 471
2025
Q3 		$5.01M Sell
248,139
-12,400
-5% -$218K 0.01% 538
2025
Q2 		$4.37M Buy
260,539
+20,900
+9% +$337K 0.01% 545
2025
Q1 		$3.68M Sell
239,639
-2,700
-1% -$48.2K 0.01% 580
2024
Q4 		$5.34M Buy
242,339
+22,200
+10% +$404K 0.02% 525
2024
Q3 		$3.97M Buy
220,139
+24,800
+13% +$434K 0.01% 582
2024
Q2 		$3.17M Buy
195,339
+3,900
+2% +$60.1K 0.01% 591
2024
Q1 		$2.7M Buy
+191,439
New +$2.41M 0.01% 642

Other funds holding TEVA

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
HIIFS
Harel Insurance Investments & Financial Services Ramat Gan, Israel $14.7B AUM 47% 1-Year Est. Return
PF
Phoenix Financial Givatayim, Israel $10.5B AUM 49.21% 1-Year Est. Return
MMH
Menora Mivtachim Holdings Ramat Gan, Israel $21.1B AUM 40.03% 1-Year Est. Return
WCM Investment Management
WCM Investment Management Laguna Beach, California $43.8B AUM 42.28% 1-Year Est. Return
CI
Clal Insurance Tel-Aviv, Israel $16.6B AUM 68.34% 1-Year Est. Return
MIFH
Migdal Insurance & Financial Holdings Petach Tikva, Israel $11.5B AUM 52.5% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
LIM
Lingotto Investment Management London, United Kingdom $5.06B AUM 91.14% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Danske Bank's TEVA Position: Q1 2026 in Review

Danske Bank increased its Teva Pharmaceuticals (TEVA) stake by 4.5% in Q1 2026, buying an estimated $399K and bringing the position to 284,939 shares worth $8.58M. The position accounts for 0.02% of the portfolio, ranked #461.

Danske Bank first reported a position in TEVA in Q1 2024 and has held it in 9 quarters since. 650 funds tracked by Wall St. Rank hold TEVA as of Q1 2026.

  • Danske Bank held 284,939 shares of Teva Pharmaceuticals worth $8.58M as of Q1 2026.
  • Danske Bank bought 12,400 Teva Pharmaceuticals shares in Q1 2026, an estimated $399K.
  • Teva Pharmaceuticals made up 0.02% of Danske Bank's portfolio in Q1 2026, its #461 holding.
  • Danske Bank first reported a position in Teva Pharmaceuticals in Q1 2024 and has held it in 9 quarters since.
  • 650 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q1 2026.

Based on Danske Bank's 13F filing for Q1 2026, filed 12 May 2026.